Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soymilk in Children With NAFLD
NCT06133101Phase 2Recruiting
- Start
- Jan 2024
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 2, randomised trial in non-alcoholic fatty liver disease (NAFLD) (2 arms). Primary endpoint: Change in liver disease severity at 12 weeks. Started Jan 2024; status: recruiting.
02
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06133101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06133101.